Post-genomic clinical trials: the perspective of ACGT.

Graf N, Desmedt C, Buffa F, Kafetzopoulos D, Forgó N, Kollek R, Hoppe A, Stamatakos G, Tsiknakis M

Open source

DOI
10.3332/ecms.2008.66
Published
2008
Container
Ecancermedicalscience
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3332/ecms.2008.66,
  title = {Post-genomic clinical trials: the perspective of ACGT.},
  author = {Graf N and Desmedt C and Buffa F and Kafetzopoulos D and Forgó N and Kollek R and Hoppe A and Stamatakos G and Tsiknakis M},
  year = {2008},
  journal = {Ecancermedicalscience},
  doi = {10.3332/ecms.2008.66},
  url = {https://doi.org/10.3332/ecms.2008.66}
}

RIS

TY  - JOUR
TI  - Post-genomic clinical trials: the perspective of ACGT.
AU  - Graf N
AU  - Desmedt C
AU  - Buffa F
AU  - Kafetzopoulos D
AU  - Forgó N
AU  - Kollek R
AU  - Hoppe A
AU  - Stamatakos G
AU  - Tsiknakis M
PY  - 2008
JO  - Ecancermedicalscience
DO  - 10.3332/ecms.2008.66
UR  - https://doi.org/10.3332/ecms.2008.66
ER  - 

APA

N, G., C, D., F, B., D, K., N, F., R, K., A, H., G, S., & M, T. (2008). Post-genomic clinical trials: the perspective of ACGT.. Ecancermedicalscience. https://doi.org/10.3332/ecms.2008.66

Source records